Panacea Index Logo

Command Palette

Search for a command to run...

Metal Complexation Mechanisms of Polyphenols Associated to Alzheimer's Disease.

Current medicinal chemistry
January 1, 2021
Arian Kola et al. (3 authors)
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to analyze the metal complexation mechanisms of polyphenols, particularly their interaction with metal ions like copper, in the context of Alzheimer's disease.

Results Summary

The abstract discusses polyphenols' antioxidant properties, metal chelating features, and anti-aggregating behavior, but does not provide specific results regarding copper's effects.

Population

Not specified (focus on Alzheimer's disease mechanisms).

Effective Dosage

Not available.

Duration

Not specified.

Interactions

None mentioned.

Extracted Claims (7)
InterventionDirectionEndpointPopulationDosageImpactClaim #
polyphenols
increase
antioxidant activity
-
-
act as potent antioxidants
#1
polyphenols
decrease
cancer
-
-
prevention and treatment
#2
several polyphenols
increase
neuronal health
-
-
neuroprotective effects
#3
a plethora of polyphenols
decrease
cancer, cardiac and neuronal diseases
-
-
ameliorating effects
#4
polyphenols
decrease
oxidative stress
Alzheimer's disease
-
antioxidant properties
#5
polyphenols
decrease
metal ion dyshomeostasis
Alzheimer's disease
-
metal chelating features
#6
polyphenols
decrease
protein aggregation
Alzheimer's disease
-
anti-aggregating behavior
#7
Abstract

Polyphenols are a class of compounds, produced by plants, which share the ability to act as potent antioxidants. First investigations on polyphenols' antioxidant activity are dated almost twenty years ago when their relationship and implication with the prevention and treatment of cancer was proposed for the first time. Later, in the early 2000s, the neuroprotective effects of several polyphenols were demonstrated. Nowadays, the benefits of a plethora of polyphenols have been studied and their ameliorating effects in several disease conditions, like cancer, cardiac and neuronal diseases are widely recognised. More than 1000 papers dealing with polyphenols and Alzheimer's disease have been published so far, describing the antioxidant properties, the metal chelating features and the anti-aggregating behavior of these compounds. The aim of this review is to rationalize, from a chemical point of view, the metal complexation mechanisms of polyphenols related to two significant events of Alzheimer's disease: oxidative stress and metal ion dyshomeostasis. In order to address this issue, we have herein discussed several aspects implicated in Alzheimer's disease and polyphenols involved in the treatment of the disease.

Medical Subject Headings (MeSH)
Alzheimer DiseaseAmyloid beta-PeptidesAntioxidantsChelating AgentsHumansPolyphenols
Study Links
Quality Scores
SafetyNot Assessed
Quality75/10
Citation Metrics
Total Citations8
Citations/Year2.0
Relative Citation Ratio0.88
NIH Percentile45.6%
Research Impact Scores
APT Score0.25
Weight Score2.34
Normalized Score0.55
Related Supplements